Ring vaccination may not be effective against monkeypox: Study
Last Updated August 07, 2022
Share
New Delhi, Aug 7 (IANS): Even as the health experts from around the globe have been stressing on the need to implement ring vaccination among the people at risk with monkeypox, a new study, not peer-reviewed yet, has claimed that the strategy may not be completely effective in curbing the current outbreak. Ring vaccination, which has been used successfully to contain smallpox and Ebola outbreaks, means to vaccinate a "ring" of people around the infected rather than vaccinating an entire population, ideally within four days of exposure. The study led by a team, including from Universite Paris Cite in France, showed that ring vaccination may not completely protect against infections. The findings were based on a third-generation smallpox vaccine recommended in France for individuals who had a high-risk contact with a PCR-confirmed Monkeypox patient. The study aimed to describe the outcomes of high-risk contacts receiving third-generation smallpox vaccine as an early post-exposure ring vaccination (EPRV) especially tolerance and potential breakthrough infections after the first dose. The team performed an observational analysis of all consecutive individuals vaccinated with the IMVANEX smallpox vaccine after a high-risk contact. It was defined as close skin-to-skin or mucosal contact and/or indirect contact on textile or surface and/or droplets exposure defined by a contact at less than 2 meters during at least 3 hours with a PCR-confirmed Monkeypox patient. Between May 27 and July 13, 276 individuals received one dose of IMVANEX with a median delay of 11 days after exposure with a confirmed Monkeypox patient. Mode of exposure was droplets for 240 patients (91 per cent), indirect contact for 189 (71 per cent) and unprotected sexual intercourse for 146 (54 per cent). Most of the patients were men (91 per cent) and men who have sex with men (88 per cent). The vaccine was well tolerated with no severe adverse event. Among the 276 vaccinated individuals, 12 (4 per cent) had a confirmed Monkeypox breakthrough infection with no severe infection. Ten out of 12 patients developed a Monkeypox infection in the five days following vaccination and two had a breakthrough infection at 22 and 25 days. "EPRV with a third-generation smallpox vaccine was well tolerated and effective against Monkeypox but did not completely prevent breakthrough infections," the researchers wrote in the paper posted online.
You Might Also Like
More From Related News
Services of some special trains extended: Know the trains passing through Odisha
EC suspends 3 senior police officers of Hyderabad in cash seizure case
Fire breaks out at chemical plant in Gujarat, 24 workers hospitalized
Free food grains for 81.35 cr beneficiaries for 5 years
Cabinet approves providing drones to women SHGs
MLA inaugurates road supposed to be done by Rahul Gandhi in Wayanad
Man killed for stealing cauliflower in Bihar
PM Modi speaks to rescued Uttarakhand tunnel workers
Mines Ministry to launch first ever tranche of critical and strategic minerals auction
NTPC Bongaigaon recognized for its outstanding achievements in CSR and Environment Protection
BRS leader threatens suicide if people don’t vote for him
NDA Expo Autumn Term 2023 kick-starts in National Defence Academy
MOD inks contract with BHEL to procure 16 Upgraded Super Rapid Gun Mount & accessories
Ministry of Coal reviews Coal Production from Commercial & Captive Mines
NASA chief calls on Dr Jitendra Singh, discusses launching joint Satellite with ISRO
Gold Medal to Ministry of Ayush for excellent performance in IITF
PM to distribute more than 51,000 appointment letters to newly inducted recruits on Nov 30
It is essential to help people get legal assistance: President Murmu
41 workers freed from trapped Uttarkashi tunnel
SRC warns of probable cyclonic storm over BOB: Fishermen alerted not to venture into sea